Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors

High activities of the neutrophil proteases, elastase and cathepsin G, are found in the sputum of patients with cystic fibrosis (CF). Because both proteases have been shown to be potent secretagogues for airway submucosal glands, and because hypersecretion is a characteristic feature of CF, the objective of the present study was to examine whether there is secretagogue activity in CF sputum, and to determine the contribution of neutrophil proteases to the secretagogue activity. Confluent monolayers of cultured bovine tracheal serous cells were pulse-labelled with Na2(35)SO4, incubated with diluted CF sputum supernatants in the presence or absence of different protease inhibitors, and the subsequent release of the radio-labelled macromolecules was measured. CF sputum potently induced secretion concentration-dependently. Addition of the selective neutrophil elastase inhibitor ICI 200,355 inhibited the secretory response to CF sputum supernatant by 89%. Addition of a cathepsin G-inhibitor resulted in further inhibition of the secretory response. Addition of phosphoramidon, a drug known to inhibit Pseudomonas aeruginosa elastase, had no effect. We conclude that CF sputum potently stimulates airway submucosal gland cell secretion. These studies with protease inhibitors suggest that neutrophil proteases account substantially for the secretagogue activity present in CF sputum.

This article has been cited by other articles:

				J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease J. Leukoc. Biol., April 1, 2008; 83(4): 946 - 955. [Abstract] [Full Text] [PDF]

				T. D. Starner and P. B. McCray Jr. Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity To Eradicate Bacteria Ann Intern Med, December 6, 2005; 143(11): 816 - 822. [Full Text] [PDF]

				F Rubio, J Cooley, F J Accurso, and E Remold-O'Donnell Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease Thorax, April 1, 2004; 59(4): 318 - 323. [Abstract] [Full Text] [PDF]

				V. Witko-Sarsat, L. Halbwachs-Mecarelli, A. Schuster, P. Nusbaum, I. Ueki, S. Canteloup, G. Lenoir, B. Descamps-Latscha, and J. A. Nadel Proteinase 3, a Potent Secretagogue in Airways, Is Present in Cystic Fibrosis Sputum Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 729 - 736. [Abstract] [Full Text]

				J. E. Gern and W. W. Busse Association of Rhinovirus Infections with Asthma Clin. Microbiol. Rev., January 1, 1999; 12(1): 9 - 18. [Abstract] [Full Text] [PDF]

				D. D. Rees, R. A. Rogers, J. Cooley, R. J. Mandle, D. M. Kenney, and E. Remold-O'Donnell Recombinant Human Monocyte/Neutrophil Elastase Inhibitor Protects Rat Lungs against Injury from Cystic Fibrosis Airway Secretions Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 69 - 78. [Abstract] [Full Text]

				H. Liu, S. C. Lazarus, G. H. Caughey, and J. V. Fahy Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L28 - L34. [Abstract] [Full Text] [PDF]